Jefferies Group set a $46.00 price target on Envision Healthcare (NYSE:EVHC) in a research report report published on Thursday, March 15th. The brokerage currently has a buy rating on the stock.
A number of other research analysts also recently commented on the company. Credit Suisse Group initiated coverage on Envision Healthcare in a research note on Monday, December 11th. They issued an outperform rating and a $36.00 price target for the company. Cantor Fitzgerald reaffirmed a hold rating and issued a $37.00 price target on shares of Envision Healthcare in a research note on Friday, January 5th. ValuEngine downgraded Envision Healthcare from a buy rating to a hold rating in a research note on Friday, February 2nd. Zacks Investment Research raised Envision Healthcare from a strong sell rating to a hold rating in a research note on Tuesday, January 2nd. Finally, Mizuho set a $31.00 price target on Envision Healthcare and gave the company a neutral rating in a research note on Friday, November 17th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the company. Envision Healthcare presently has an average rating of Hold and a consensus price target of $42.57.
Shares of EVHC traded down $1.11 during midday trading on Thursday, reaching $37.79. 2,066,619 shares of the stock were exchanged, compared to its average volume of 2,354,322. Envision Healthcare has a twelve month low of $23.77 and a twelve month high of $64.00. The company has a debt-to-equity ratio of 0.87, a quick ratio of 3.38 and a current ratio of 3.40. The company has a market capitalization of $4,569.76, a P/E ratio of 15.24, a P/E/G ratio of 0.87 and a beta of 0.42.
Envision Healthcare (NYSE:EVHC) last posted its earnings results on Tuesday, February 27th. The company reported $0.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.45 by $0.14. Envision Healthcare had a positive return on equity of 4.62% and a negative net margin of 2.52%. The company had revenue of $2 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter last year, the firm earned $1.15 earnings per share. The company’s revenue was up 68.0% on a year-over-year basis. equities research analysts predict that Envision Healthcare will post 3.34 earnings per share for the current fiscal year.
Institutional investors have recently added to or reduced their stakes in the business. CIBC World Markets Inc. bought a new position in Envision Healthcare in the fourth quarter valued at about $208,000. OLD Mutual Customised Solutions Proprietary Ltd. grew its holdings in shares of Envision Healthcare by 88.2% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 6,401 shares of the company’s stock worth $221,000 after purchasing an additional 3,000 shares during the last quarter. CENTRAL TRUST Co grew its holdings in shares of Envision Healthcare by 79.7% during the fourth quarter. CENTRAL TRUST Co now owns 6,626 shares of the company’s stock worth $229,000 after purchasing an additional 2,939 shares during the last quarter. Alps Advisors Inc. bought a new stake in shares of Envision Healthcare during the fourth quarter worth about $235,000. Finally, M&T Bank Corp grew its holdings in shares of Envision Healthcare by 33.6% during the fourth quarter. M&T Bank Corp now owns 6,818 shares of the company’s stock worth $235,000 after purchasing an additional 1,716 shares during the last quarter.
TRADEMARK VIOLATION WARNING: This report was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/04/08/envision-healthcare-evhc-pt-set-at-46-00-by-jefferies-group.html.
Envision Healthcare Company Profile
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.